drugset
drugset / Trial / NCT03577626

A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers

NCT03577626 ↗

Phase 1 Unknown 12 enrolled Tianjin Hemay Bio-Tech Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of food on the PK of a single dose of 52.5 mg Hemay005 in healthy subjects.

Timeline

Start
2018-10-10
Primary completion
2018-11-10
Completion
2019-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject MUFEMILAST Small molecule 52.5 mg Oral

Indications

psoriasis